This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Solinas, E. Articles by Mehran, R. Search for Related Content PubMed Articles by Solinas, E. Articles by Mehran, R.

Gender-Specific Outcomes After Sirolimus-Eluting Stent Implantation

Emilia Solinas, MD, PhD^_*, Eugenia Nikolsky, MD, PhD, FACC^_*, Alexandra J. Lansky, MD, FACC^_*, Ajay J. Kirtane, MD, SM^_*, Marie-Claude Morice, MD, FACC, Jeffrey J. Popma, MD, FACC, Joachim Schofer, MD, Erick Schampaert, MD^||, Tereza Pucelikova, MD^_*, Jiro Aoki, MD^_*, Martin Fahy, MSc^_*, George D. Dangas, MD, PhD, FACC^_*, Jeffrey W. Moses, MD, FACC^_*, Donald E. Cutlip, MD, FACC^¶, Martin B. Leon, MD, FACC^_* and Roxana Mehran, MD, FACC^_*,_*

^_* Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
Institut Cardiovasculaire Paris Sud, Massy, France
Brigham and Women’s Hospital, Boston, Massachusetts
Centre for Cardiology and Vascular Intervention, Hamburg, Germany
^|| Hopital Sacre-Coeur de Montreal, Montreal, PQ, Canada
^¶ Harvard Clinical Research Institute, Boston, Massachusetts.

View larger version (10K): [in this window] [in a new window] [Download PPT slide]   Figure 1 One-Year Survival Free From MACE in Men and Women (A) Kaplan-Meier curves of 1-year major adverse cardiac events (MACE)-free survival in men treated with percutaneous coronary intervention using sirolimus-eluting stents (SES) versus bare-metal stents (BMS). (B) Kaplan-Meier curves of 1-year MACE-free survival in women treated with percutaneous coronary intervention using SES versus BMS.